This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

TIDES Europe: Oligonucleotide and Peptide Therapeutics

SAVINGS DEADLINE EXPIRES:

  • 00
    Days
  • 00
    Hrs
  • 00
    Mins
  • 00
    Secs
Delivered as Hybrid Event from 16-18 November 2022
Live In-Person Conference Delivered 16-18 NovemberAustria Center Vienna

Michael Ruehl, PhD
Head of Quality Control Lab at BioSpring GmbH

Profile

2010-2014           Pharmaceutical sciences study at Goethe University Frankfurt

Since 2015          Registered Pharmacist in Germany

2015-2019           Ph.D. in Pharmaceutical Chemistry in the Working group Prof. Dr. Karas in the field of protein mass spectrometry

2016-2020           Specialization program in Pharmaceutical Analytics

Since 2019          Head of Quality Control Lab at BioSpring GmbH

Agenda Sessions

  • Sequence Confirmation of Long Oligonucleotides: Mass Spectrometric Investigations

    14:30